These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 5825146)

  • 1. Cardiac arrest occurring in a patient on echothiophate iodide therapy.
    Hiscox PE; McCulloch C
    Am J Ophthalmol; 1965 Sep; 60(3):425-7. PubMed ID: 5825146
    [No Abstract]   [Full Text] [Related]  

  • 2. Echothiophate iodide treatment of glaucoma in pregnancy.
    Birks DA; Prior VJ; Silk E; Whittaker M
    Arch Ophthalmol; 1968 Mar; 79(3):283-5. PubMed ID: 5640850
    [No Abstract]   [Full Text] [Related]  

  • 3. Echothiophate iodide. The effect of 0.0625 per cent solution on blood cholinesterase.
    Wahl JW; Tyner GS
    Am J Ophthalmol; 1965 Sep; 60(3):419-25. PubMed ID: 5317880
    [No Abstract]   [Full Text] [Related]  

  • 4. Blood cholinesterase activity of glaucoma patients treated with phospholine iodide.
    De Roetth A; Wong A; Dettbarn W; Rosenberg P; Wilensky JG
    Am J Ophthalmol; 1966 Nov; 62(5):834-8. PubMed ID: 5928831
    [No Abstract]   [Full Text] [Related]  

  • 5. The effect of echothiophate iodide on systemic cholinesterase.
    Hiscox PE; McCulloch C
    Can J Ophthalmol; 1966 Oct; 1(4):274-82. PubMed ID: 5977437
    [No Abstract]   [Full Text] [Related]  

  • 6. Lens opacities in glaucoma patients on phospholine iodide therapy.
    De Roetth A
    Am J Ophthalmol; 1966 Oct; 62(4):619-28. PubMed ID: 5929123
    [No Abstract]   [Full Text] [Related]  

  • 7. Cholinergic toxicity resulting from ocular instillation of echothiophate iodide eye drops.
    Manoguerra A; Whitney C; Clark RF; Anderson B; Turchen S
    J Toxicol Clin Toxicol; 1995; 33(5):463-5. PubMed ID: 7650771
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of phospholine iodide eye drops on blood cholinesterase in glaucoma patients.
    Ben-Dor D; Weisenberg E
    Isr J Med Sci; 1966; 2(5):624-5. PubMed ID: 5970651
    [No Abstract]   [Full Text] [Related]  

  • 9. Lens opacities in glaucoma patients on phospholine iodide therapy.
    De Roetth A
    Trans Ophthalmol Soc U K (1962); 1966; 86():89-100. PubMed ID: 5226620
    [No Abstract]   [Full Text] [Related]  

  • 10. Lenticular opacities in glaucoma patients receiving echothiophate iodide therapy. Preliminary report.
    De Roetth A
    JAMA; 1966 Feb; 195(8):664-6. PubMed ID: 5951770
    [No Abstract]   [Full Text] [Related]  

  • 11. Glaucoma, miotic therapy and cataract. V. Studies on the lens in glaucoma eyes after discontinuance of echothiophate (phospholine iodide) therapy.
    Axelsson U
    Acta Ophthalmol (Copenh); 1969; 47(4):1049-56. PubMed ID: 5394838
    [No Abstract]   [Full Text] [Related]  

  • 12. EFFECT OF PHOSPHOLINE IODIDE ON BLOOD CHOLINESTERASE LEVELS OF NORMAL AND GLAUCOMA SUBJECTS.
    DEROETTH A; DETTBARN WD; ROSENBERG P; WILENSKY JG; WONG A
    Am J Ophthalmol; 1965 Apr; 59():586-92. PubMed ID: 14270995
    [No Abstract]   [Full Text] [Related]  

  • 13. Echothiophate iodide induced transient hyper- and hypothyroidism.
    Mezer E; Krivoy N; Scharf J; Miller B
    J Glaucoma; 1996 Jun; 5(3):191-2. PubMed ID: 8795758
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glaucoma, miotic therapy and cataract. 3. Visual loss due to lens changes in glaucoma eyes treated with paraoxon (Mintacol), echothiophate (phospholine iodide) or pilocarpine.
    Axelsson U
    Acta Ophthalmol (Copenh); 1968; 46(4):831-45. PubMed ID: 5755701
    [No Abstract]   [Full Text] [Related]  

  • 15. Glaucoma, miotic therapy and cataract. I. The frequency of anterior subcapsular vacuoles in glaucoma eyes treated with echothiophate (Phospholine Iodide), pilocarpine or pilocarpine-eserine, and in nonglaucomatous untreated eyes with common senile cataract.
    Axelsson U
    Acta Ophthalmol (Copenh); 1968; 46(1):83-98. PubMed ID: 5694669
    [No Abstract]   [Full Text] [Related]  

  • 16. Cystoid macular edema associated with topical echothiophate iodide.
    Halperin LS; Goldman HB
    Ann Ophthalmol; 1993 Dec; 25(12):457-8. PubMed ID: 8129329
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Allergic contact dermatitis to echothiophate iodide and phenylephrine.
    Mathias CG; Mailbach HI; Irvine A; Adler W
    Arch Ophthalmol; 1979 Feb; 97(2):286-7. PubMed ID: 550798
    [No Abstract]   [Full Text] [Related]  

  • 18. Dose-response analysis of echothiophate iodide.
    Harris LS
    Arch Ophthalmol; 1971 Nov; 86(5):503-5. PubMed ID: 5114443
    [No Abstract]   [Full Text] [Related]  

  • 19. Lens opacities and organophosphate cholinesterase-inhibiting agents.
    Pietsch RL; Bobo CB; Finklea JF; Vallotton WW
    Am J Ophthalmol; 1972 Feb; 73(2):236-42. PubMed ID: 5015904
    [No Abstract]   [Full Text] [Related]  

  • 20. Results of preoperative antiglaucomatous treatment and of Scheie's operation.
    Douglas WH; Ramsell TG
    Br J Ophthalmol; 1969 Jul; 53(7):472-6. PubMed ID: 5804032
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.